v3.25.1
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Product Information [Line Items]            
Loss from operations   $ 228,000 $ (333,000) $ 753,000 $ (69,000)  
Net cash used in operating activities       624,000 (165,000)  
Accumulated deficit   26,725,000   26,725,000   $ 26,847,000
Exchange for cash       880,000 0  
Cash in amount   432,000   432,000   179,000
Cash equivalents   0   0   0
Write-down of investment   1,000   1,000   1,000
Research and development expense   42,000 $ 9,000 66,000 $ 45,000  
Receivables from customers   $ 122,000   $ 122,000   $ 0
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Desmet [Member]            
Product Information [Line Items]            
Concentration risk, percentage       100.00% 100.00%  
Accounts Payable [Member] | Customer Concentration Risk [Member] | Vendor One [Member]            
Product Information [Line Items]            
Concentration risk, percentage       21.00%   19.00%
Accounts Payable [Member] | Customer Concentration Risk [Member] | Vendor Two [Member]            
Product Information [Line Items]            
Concentration risk, percentage       20.00%   15.00%
Accounts Payable [Member] | Customer Concentration Risk [Member] | Vendor Three [Member]            
Product Information [Line Items]            
Concentration risk, percentage       13.00%   11.00%
Patent Transfer To Desmet [Member]            
Product Information [Line Items]            
Exchange for cash $ 880,000